$69.08

-0.55 (-0.79%)

5/16/2008 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View Ticker Page (GENZ)

Results 1 - 10 of 33 : 1 2 3 4

Recs

5

Avatar NetscribeBiotech (66.48) Submitted: 2/27/07 1:55 AM : Start Price: $63.01 GENZ Score: 10.48

Genzyme Corporation is a global biotechnology company focused on developing products for medical needs in six broad medical areas viz. genetic diseases, renal disease, orthopaedics, transplant and immune diseases, oncology, and diagnostics. The key p...

Report this Post Replies: 1 | Reply | Permalink

Recs

3

Avatar Firesale (82.19) Submitted: 3/28/07 12:36 PM : Start Price: $59.88 GENZ Score: 15.06

Foward PE of 16.51, the company's sales have grown by 16.5% for the 12-month period, has "promising" products under development to treat genetic diseases, kidney disease and cancer among other conditions, and shares are down over 12%
since Janu...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar madiasha (< 20) Submitted: 5/03/07 1:09 PM : Start Price: $66.02 GENZ Score: 9.62

GENZ looks too much like a takeover target because of product and pipeline.Value is much more than present capitalization.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar tkies60537 (80.52) Submitted: 12/08/06 7:35 PM : Start Price: $61.74 GENZ Score: 11.01

Genzyme makes mad money in diseases. The company's product portfolio focuses on rare genetic disorders as well as organ transplant, osteoarthritis, and renal disease. One of its main products, Cerezyme, is a leading (and pricey) treatment for Gaucher...

Report this Post Replies: 1 | Reply | Permalink

Recs

1

Avatar cerebos (98.65) Submitted: 7/06/07 4:35 PM : Start Price: $61.20 GENZ Score: -19.73

Great company but will be punished in the short term for having had unsuccessful outcomes of two clinical trials.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar GhentTeach (87.24) Submitted: 3/01/07 11:31 AM : Start Price: $61.53 GENZ Score: 11.19

may benefit from high volatility

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar StockTalking (47.37) Submitted: 8/16/07 12:03 PM : Start Price: $59.26 GENZ Score: -13.25

out for cash.

http://mystockmistakes.blogspot.com/

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar picks007 (< 20) Submitted: 12/05/06 11:17 PM : Start Price: $62.87 GENZ Score: 8.33

lowest price in months, time for a bounce back for year's end

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar extremeinvesting (97.41) Submitted: 11/01/06 11:19 AM : Start Price: $67.44 GENZ Score: -0.81

GENZ is an extreme performance investing stock with a niche in products that are targeted at rare and specific diseases, to include diagnostic products and services.

Report this Post Replies: 0 | Reply | Permalink